Literature DB >> 2553654

Itraconazole and fluconazole: new drugs for deep fungal infection.

D W Warnock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2553654     DOI： 10.1093/jac/24.3.275

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Standardized susceptibility testing of fluconazole: an international collaborative study.

Authors:  M A Pfaller; B Dupont; G S Kobayashi; J Müller; M G Rinaldi; A Espinel-Ingroff; S Shadomy; P F Troke; T J Walsh; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.

Authors:  A Gil; P Lavilla; E Valencia; V Pintado; M L Dupla; M A Khamashta; J García-Puig; J Ortiz-Vázquez
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 4.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

5.  Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention.

Authors:  Shingo Miyamoto; Takumi Narita; Masami Komiya; Gen Fujii; Takahiro Hamoya; Ruri Nakanishi; Shuya Tamura; Yurie Kurokawa; Maiko Takahashi; Michihiro Mutoh
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

Review 6.  Recent advances in drug repositioning for the discovery of new anticancer drugs.

Authors:  Joong Sup Shim; Jun O Liu
Journal:  Int J Biol Sci       Date:  2014-06-10       Impact factor: 6.580

Review 7.  Treatment of sepsis in an intensive care unit.

Authors:  C C Smith
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.